Actively Recruiting
Fostering Prosocial Preventive Behaviours Through Awe
Led by The University of Hong Kong · Updated on 2026-02-27
456
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this randomized control trial is to investigate the impact pf awe on prosocial preventive behaviours against infectious diseases among adults from Hong Kong, Singapore, and ten major cities in Mainland China (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing). The main questions it aims to answer are: * Does experiencing awe increase adults' intentions to engage in prosocial preventive behaviours against infectious diseases, including vaccination, mask wearing, and social distancing? * Does the impact vary across three research sites?
CONDITIONS
Official Title
Fostering Prosocial Preventive Behaviours Through Awe
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Lived in Hong Kong, Singapore, or one of ten major Mainland China cities (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing) for at least one year
- Able to read and understand written Chinese or English
- Have internet access via computer, mobile phone, or tablet
You will not qualify if you...
- Individuals with cognitive or language difficulties that prevent completing an online survey
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Hong Kong School of Public Health
Hong Kong, Hong Kong
Actively Recruiting
Research Team
Q
Qiuyan Liao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here